Literature DB >> 9530105

Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts.

A M Delany1, E Canalis.   

Abstract

Osteonectin (secreted protein acidic and rich in cysteine, 40-kDa basement membrane) is a glycoprotein abundantly expressed in bone and in other tissues undergoing active remodeling. Fibroblast growth factors (FGFs) are important in skeletal development and fracture repair, events associated with extracellular matrix remodeling. We used the murine osteoblastic cell line MC3T3 to determine whether basic FGF (bFGF) regulates osteonectin expression in bone. Northern blot analysis showed that bFGF decreased osteonectin transcripts in a dose- and time-dependent manner. This regulation was independent of the mitogenic effect of bFGF but was dependent on new protein synthesis. Immunoprecipitation of [35S]methionine-cysteine osteoblast-conditioned medium and cell layer proteins showed that bFGF decreased osteonectin synthesis. Nuclear runoff assays failed to reveal regulation of osteonectin gene transcription by bFGF. However, bFGF dramatically decreased the stability of osteonectin mRNA in transcriptionally arrested osteoblasts. This destabilization of osteonectin mRNA may be one means by which bFGF regulates extracellular matrix remodeling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530105     DOI: 10.1152/ajpcell.1998.274.3.C734

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.

Authors:  Kristina Kapinas; Catherine B Kessler; Anne M Delany
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

2.  A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433.

Authors:  Neha S Dole; Kristina Kapinas; Catherine B Kessler; Siu-Pok Yee; Douglas J Adams; Renata C Pereira; Anne M Delany
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

3.  Osteopenia and decreased bone formation in osteonectin-deficient mice.

Authors:  A M Delany; M Amling; M Priemel; C Howe; R Baron; E Canalis
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Functional analysis of BMP4 mutations identified in pediatric CAKUT patients.

Authors:  Mansoureh Tabatabaeifar; Karl-Peter Schlingmann; Mieczyslaw Litwin; Sevinc Emre; Aysin Bakkaloglu; Otto Mehls; Corinne Antignac; Franz Schaefer; Stefanie Weber
Journal:  Pediatr Nephrol       Date:  2009-08-14       Impact factor: 3.714

5.  Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

Authors:  A M Delany; D J McMahon; J S Powell; D A Greenberg; E S Kurland
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

6.  bFGF stimulated plasminogen activation factors, but inhibited alkaline phosphatase and SPARC in stem cells from apical Papilla: Involvement of MEK/ERK, TAK1 and p38 signaling.

Authors:  Mei-Chi Chang; Nai-Yuan Chen; Jen-Hao Chen; Wei-Ling Huang; Chi-Yu Chen; Chih-Chia Huang; Yu-Hwa Pan; Hsiao-Hua Chang; Jiiang-Huei Jeng
Journal:  J Adv Res       Date:  2021-12-28       Impact factor: 12.822

7.  Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.

Authors:  Anne M Delany; Kurt David Hankenson
Journal:  J Cell Commun Signal       Date:  2009-10-28       Impact factor: 5.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.